Changes in brain metabolites measured with magnetic resonance spectroscopy in antidepressant responders with comorbid major depression and posttraumatic stress disorder;Promjene razina moždanih metabolita mjerenih magnetskom rezonantnom spektroskopijom u ispitanika s komorbiditetom depresije i posttraumatskog stresnog poremećaja koji su odgovorili na antidepresivno liječenje

Collegium Antropologicum

Volumn 35, Issue SUPPL. 1, 2011, Pages 145-148

  Henigsberg, Neven ^a,b   Bajs, Maja ^a   Hrabač, Pero ^b   Kalember, Petra ^a,b   Radoš, Marko ^c   Radoš, Milan ^b   Radonić, Elizabeta ^b  

^a Referentni centar za Alzheimerovu bolest i psihijatriju sta rijeivo t ne dobi   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

Major depression; PTSD; Spectroscopy; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BRAIN; BRAIN LEVEL; COHORT ANALYSIS; DRUG EFFECT; HUMAN; MAJOR DEPRESSION; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTTRAUMATIC STRESS DISORDER;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN CHEMISTRY; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 79952010905     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. NORTH CS, SMITH EM, SPITZNAGEL EL, Am J Psychiatry, 151 (1994) 82.
2. BRESLAU N, DAVIS GC, ANDRESKI P, PETERSON E, Arch Gen Psychiatry, 48 (1991) 216.
3. BLANCHARD EB, BUCKLEY TC, HICKLING EJ, TAYLOR AE, J Anxiety Disord, 12 (1998) 21.
4. KESSLER RC, SONNEGA A, BROMET E, HUGHES M, NELSON CB, Arch Gen Psychiatry, 52 (1995) 1048.
5. BLANCHARD EB, HICKLING EJ, TAYLOR AE, LOOS W, J Nerv Ment Dis, 183 (1995) 495.
6. KRAMER TL, LINDY JD, GREEN BL, GRACE MC, LEONARD AC, Suicide Life Threat Behav, 24 (1994) 58.
7. MAES M, MYLLE J, DELMEIRE L, ALTAMURA C, Eur Arch Psychiatry Clin Neurosci, 250 (2000) 156.
8. PRIEBE S, BOGIC M, AJDUKOVIC D, FRANCISKOVIC T, GALEAZZI GM, KUCUKALIC A, LECIC-TOSEVSKI D, MORINA N, POPOVSKI M, WANG D, SCHÜTZWOHL M, Arch Gen Psychiatry, 67 (2010) 518.
9. KESSLER RC, CHIU WT, DEMLER O, MERIKANGAS KR, WALTERS EE, Arch Gen Psychiatry, 62 (2005) 617.
10. KESSLER RC, BERGLUND P, DEMLER O, JIN R, KORETZ D, MERIKANGAS KR, RUSH AJ, WALTERS EE, WANG PS, JAMA, 289 (2003) 3095.
11. SOUTHWICK SM, YEHUDA R, GILLER EL JR, Am J Psychiatry, 148 (1991) 179.
12. DOW B, KLINE N, Ann Clin Psychiatry, 9 (1997) 1.
13. MICHAEL N, ERTFUTH A, OHRMANN P, AROLT V, HEINDEL W, PFLEIDERER B, Psychol Med, 33 (2003) 1277.
14. CAETANO SC, FONSECA M, OLVERA RL, Neurosci Lett, 384 (2005) 321.
15. DEN HEIJER T, SIJENS PE, PRINS ND, HOFMAN A, KOUDSTAAL PJ, OUDKERK M, Neurology, 66 (2006) 540.
16. YILDIZ-YESILOGLU A, ANKERST DP, Prog Neuropsychopharmacol Biol Psychiatry, 30 (2006) 969.
17. KAYMAK SU, DEMIR B, OČUZ KK, SENTÜRK S, ULUČ B, Psychiatry Clin Neurosci, 63 (2009) 350.
18. GRUBER S, FREY R, MLYNARIK V, Invest. Radiol, 38 (2003) 403.
19. RAJKOWSKA G, Biol. Psychiatry, 48 (2000) 766.
20. SHIMON H, AGAM G, BELMAKER RH, HYDE TM, KLEINMAN JE, Am. J.Psychiatry, 154 (1997) 1148.
21. FARCHIONE TR, MOORE GJ, ROSENBERG DR, Biol Psychiatry, 52 (2002) 86.
22. MICHAEL N, ERFURTH A, OHRMANN P, AROLT V, HEINDEL W, PFLEIDERER B, Neuropsychopharmacology, 28 (2003) 720.
23. CHARLES HC, LAZEYRAS F, KRISHNAN KR, BOYKO OB, PATTERSON LJ, DORAISWAMY PM, MCDONALD WM, Prog Neuropsychopharmacol Biol Psychiatry, 18 (1994) 995.